Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system.

Literature DB >> 22395693

Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system.

Metamia Ciampricotti, Cheei-Sing Hau, Chris W Doornebal, Jos Jonkers, Karin E de Visser.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2012 PMID： 22395693 DOI： 10.1038/nm.2652

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

10 in total

1. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

Authors: Caroline Robert; Luc Thomas; Igor Bondarenko; Steven O'Day; Jeffrey Weber; Claus Garbe; Celeste Lebbe; Jean-François Baurain; Alessandro Testori; Jean-Jacques Grob; Neville Davidson; Jon Richards; Michele Maio; Axel Hauschild; Wilson H Miller; Pere Gascon; Michal Lotem; Kaan Harmankaya; Ramy Ibrahim; Stephen Francis; Tai-Tsang Chen; Rachel Humphrey; Axel Hoos; Jedd D Wolchok
Journal: N Engl J Med Date: 2011-06-05 Impact factor: 91.245

2. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

Authors: David G DeNardo; Donal J Brennan; Elton Rexhepaj; Brian Ruffell; Stephen L Shiao; Stephen F Madden; William M Gallagher; Nikhil Wadhwani; Scott D Keil; Sharfaa A Junaid; Hope S Rugo; E Shelley Hwang; Karin Jirström; Brian L West; Lisa M Coussens
Journal: Cancer Discov Date: 2011-06-01 Impact factor: 39.397

3. Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.

Authors: Stephen R Mattarollo; Sherene Loi; Helene Duret; Yuting Ma; Laurence Zitvogel; Mark J Smyth
Journal: Cancer Res Date: 2011-06-06 Impact factor: 12.701

4. Calreticulin exposure dictates the immunogenicity of cancer cell death.

Authors: Michel Obeid; Antoine Tesniere; François Ghiringhelli; Gian Maria Fimia; Lionel Apetoh; Jean-Luc Perfettini; Maria Castedo; Grégoire Mignot; Theoharis Panaretakis; Noelia Casares; Didier Métivier; Nathanael Larochette; Peter van Endert; Fabiola Ciccosanti; Mauro Piacentini; Laurence Zitvogel; Guido Kroemer
Journal: Nat Med Date: 2006-12-24 Impact factor: 53.440

5. Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.

Authors: Rupal Ramakrishnan; Deepak Assudani; Srinivas Nagaraj; Terri Hunter; Hyun-Il Cho; Scott Antonia; Soner Altiok; Esteban Celis; Dmitry I Gabrilovich
Journal: J Clin Invest Date: 2010-03-15 Impact factor: 14.808

Review 6. Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments.

Authors: Karin Schreiber; Donald A Rowley; Gert Riethmüller; Hans Schreiber
Journal: Hematol Oncol Clin North Am Date: 2006-06 Impact factor: 3.722

7. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.

Authors: François Ghiringhelli; Lionel Apetoh; Antoine Tesniere; Laetitia Aymeric; Yuting Ma; Carla Ortiz; Karim Vermaelen; Theocharis Panaretakis; Grégoire Mignot; Evelyn Ullrich; Jean-Luc Perfettini; Frédéric Schlemmer; Ezgi Tasdemir; Martin Uhl; Pierre Génin; Ahmet Civas; Bernhard Ryffel; Jean Kanellopoulos; Jürg Tschopp; Fabrice André; Rosette Lidereau; Nicole M McLaughlin; Nicole M Haynes; Mark J Smyth; Guido Kroemer; Laurence Zitvogel
Journal: Nat Med Date: 2009-09-20 Impact factor: 53.440

8. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors: Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal: Nat Med Date: 2007-08-19 Impact factor: 53.440

9. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.

Authors: Kenneth P Olive; Michael A Jacobetz; Christian J Davidson; Aarthi Gopinathan; Dominick McIntyre; Davina Honess; Basetti Madhu; Mae A Goldgraben; Meredith E Caldwell; David Allard; Kristopher K Frese; Gina Denicola; Christine Feig; Chelsea Combs; Stephen P Winter; Heather Ireland-Zecchini; Stefanie Reichelt; William J Howat; Alex Chang; Mousumi Dhara; Lifu Wang; Felix Rückert; Robert Grützmann; Christian Pilarsky; Kamel Izeradjene; Sunil R Hingorani; Pearl Huang; Susan E Davies; William Plunkett; Merrill Egorin; Ralph H Hruban; Nigel Whitebread; Karen McGovern; Julian Adams; Christine Iacobuzio-Donahue; John Griffiths; David A Tuveson
Journal: Science Date: 2009-05-21 Impact factor: 47.728

10. Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness.

Authors: Gerald Willimsky; Melinda Czéh; Christoph Loddenkemper; Johanna Gellermann; Karin Schmidt; Peter Wust; Harald Stein; Thomas Blankenstein
Journal: J Exp Med Date: 2008-06-23 Impact factor: 14.307

10 in total

46 in total

Review 1. Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment.

Authors: Theodore S Johnson; Tracy Mcgaha; David H Munn
Journal: Adv Exp Med Biol Date: 2017 Impact factor: 2.622

2. Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.

Authors: Christina Pfirschke; Camilla Engblom; Steffen Rickelt; Virna Cortez-Retamozo; Christopher Garris; Ferdinando Pucci; Takahiro Yamazaki; Vichnou Poirier-Colame; Andita Newton; Younes Redouane; Yi-Jang Lin; Gregory Wojtkiewicz; Yoshiko Iwamoto; Mari Mino-Kenudson; Tiffany G Huynh; Richard O Hynes; Gordon J Freeman; Guido Kroemer; Laurence Zitvogel; Ralph Weissleder; Mikael J Pittet
Journal: Immunity Date: 2016-02-09 Impact factor: 31.745

3. Lack of immunoediting in murine pancreatic cancer reversed with neoantigen.

Authors: Rebecca A Evans; Mark S Diamond; Andrew J Rech; Timothy Chao; Max W Richardson; Jeffrey H Lin; David L Bajor; Katelyn T Byrne; Ben Z Stanger; James L Riley; Nune Markosyan; Rafael Winograd; Robert H Vonderheide
Journal: JCI Insight Date: 2016-09-08

4. Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.

Authors: Brian Ruffell; Debbie Chang-Strachan; Vivien Chan; Alexander Rosenbusch; Christine M T Ho; Nancy Pryer; Dylan Daniel; E Shelley Hwang; Hope S Rugo; Lisa M Coussens
Journal: Cancer Cell Date: 2014-10-16 Impact factor: 31.743

Review 5. Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors: Melissa R Junttila; Frederic J de Sauvage
Journal: Nature Date: 2013-09-19 Impact factor: 49.962

6. Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.

Authors: Assia L Angelova; Svitlana P Grekova; Anette Heller; Olga Kuhlmann; Esther Soyka; Thomas Giese; Marc Aprahamian; Gaétan Bour; Sven Rüffer; Celina Cziepluch; Laurent Daeffler; Jean Rommelaere; Jens Werner; Zahari Raykov; Nathalia A Giese
Journal: J Virol Date: 2014-02-26 Impact factor: 5.103

Review 10. Mouse models in oncoimmunology.

Authors: Laurence Zitvogel; Jonathan M Pitt; Romain Daillère; Mark J Smyth; Guido Kroemer
Journal: Nat Rev Cancer Date: 2016-09-30 Impact factor: 60.716